REQUEST A DEMO
Total
USD $0.00
Search more companies

Altis Tibbi Arastirma Organizasyon Egitim Ve Danismanlik Ltd. Sti. (Turkiye)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: Altis Tibbi Arastirma Organizasyon Egitim Ve Danismanlik Limited Sirketi Profile Updated: November 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

altis clinical research organisation provides services, guidance, and licensing solutions for the pharmaceutical and biomedical industries. Altis CRO offers a wide range of phase 1-4 clinical studies, observation research, licensing, and training in Clinical Research.

Headquarters
Metrocity No: 171/1 Esentepe Mahallesi Buyukdere Caddesi Sisli
Istanbul; Marmara;

Contact Details: Purchase the Altis Tibbi Arastirma Organizasyon Egitim Ve Danismanlik Ltd. Sti. report to view the information.

Website: http://www.altis.org

Basic Information
Total Employees:
Purchase the Altis Tibbi Arastirma Organizasyon Egitim Ve Danismanlik Ltd. Sti. report to view the information.
Outstanding Shares:
Purchase the Altis Tibbi Arastirma Organizasyon Egitim Ve Danismanlik Ltd. Sti. report to view the information.
Incorporation Date:
October 25, 2001
Key Executives
Purchase this report to view the information.
Company Manager
Company Performance
Financial values in the chart are available after Altis Tibbi Arastirma Organizasyon Egitim Ve Danismanlik Ltd. Sti. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
154.99%
Total operating revenue
154.99%
Operating profit (EBIT)
142.11%
Net Profit (Loss) for the Period
103.83%
Total assets
107.62%
Total equity
98.99%
Operating Profit Margin (ROS)
-1.31%
Net Profit Margin
-4.55%
Return on Equity (ROE)
1.48%
Quick Ratio
-0.18%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?